Overexpression of Eukaryotic translation initiation factor 3D induces stem cell-like properties and metastasis in cervix cancer by activating FAK through inhibiting degradation of GRP78

References

• Wei M, Chen Y, Du W. LncRNA LINC00858 enhances cervical cancer cell growth through miR-3064-5p/ VMA21 axis. Cancer Biomark. 2021;32:479–489.
   PubMed Web of Science ®Google Scholar
• Wang MJ, Chen JJ, Song SH, et al. Inhibition of SIRT1 limits self-renewal and oncogenesis by inducing senescence of liver cancer stem cells. J Hepatocell Carcinoma. 2021;8:685–699.
   PubMed Web of Science ®Google Scholar
• Tian Y, Luo Y, Wang J. MicroRNA-425 induces apoptosis and suppresses migration and invasion of human cervical cancer cells by targeting RAB2B. Int J Immunopathol Pharmacol. 2021;35:20587384211016131.
   Web of Science ®Google Scholar
• Massett ME, Monaghan L, Patterson S, et al. A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival. Cell Death Dis. 2021;12(6):573.
   PubMed Web of Science ®Google Scholar
• Duzcu SE, Astarci HM, Tunc N, et al. Expressions of putative cancer stem cell markers, CD44 and CD133, are correlated with pathological tumour stage in gastric adenocarcinoma. JCPSP. 2021;30(5):553–558.
   Google Scholar
• Lopez J, Poitevin A, Mendoza-Martinez V, et al. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer. 2012;12:48.
   PubMed Web of Science ®Google Scholar
• Atarashi H, Jayasinghe WH, Kwon J, et al. Artificially edited alleles of the eukaryotic translation initiation factor 4E1 gene differentially reduce susceptibility to cucumber mosaic virus and potato virus Y in tomato. Front Microbiol. 2020;11:564310.
   PubMed Web of Science ®Google Scholar
• Pan XW, Chen L, Hong Y, et al. EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling. Int J Oncol. 2016;48(6):2580–2590.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ma L, Shangguan F, et al. LAIR-1 suppresses cell growth of ovarian cancer cell via the PI3K-AKT-mTOR pathway. Aging (Albany NY). 2020;12(16):16142–16154.
   PubMedGoogle Scholar
• Latosinska A, Mokou M, Makridakis M, et al. Proteomics analysis of bladder cancer invasion: targeting EIF3D for therapeutic intervention. Oncotarget. 2017;8(41):69435–69455.
   PubMedGoogle Scholar
• Fan Y, Guo Y. Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/beta-catenin signaling pathway. Int J Clin Exp Pathol. 2015;8(9):10420–10427.
   PubMed Web of Science ®Google Scholar
• Du W, Cheng H, Peng L, et al. hmiR-34c-3p upregulation inhibits the proliferation of colon cancer cells by targeting EIF3D. Anti Cancer Drugs. 2018;29(10):975–982.
   PubMed Web of Science ®Google Scholar
• He J, Wang X, Cai J, et al. High expression of eIF3d is associated with poor prognosis in patients with gastric cancer. Cancer Manage Res. 2017;9:539–544.
   PubMed Web of Science ®Google Scholar
• Huang H, Gao Y, Liu A, et al. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation. EBioMedicine. 2019;49:189–201.
   PubMed Web of Science ®Google Scholar
• Chen HY, Chang JT, Chien KY, et al. The endogenous GRP78 interactome in human head and neck cancers: a deterministic role of cell surface GRP78 in cancer stemness. Sci Rep. 2018;8(1):536.
   PubMed Web of Science ®Google Scholar
• Li B, Cheng XL, Yang YP, et al. GRP78 mediates radiation resistance of a stem cell-like subpopulation within the MCF-7 breast cancer cell line. Oncol Rep. 2013;30(5):2119–2126.
   PubMed Web of Science ®Google Scholar
• Jang HJ, Bak Y, Pham TH, et al. STK899704 inhibits stemness of cancer stem cells and migration via the FAK-MEK-ERK pathway in HT29 cells. BMB Rep. 2018;51(11):596–601.
   PubMed Web of Science ®Google Scholar
• Datchoua Moukam AM, Embolo Owono MS, Kenfack B, et al. “Cervical cancer screening: awareness is not enough”. Understanding barriers to screening among women in West Cameroon-a qualitative study using focus groups. Reprod Health. 2021;18(1):147.
   PubMed Web of Science ®Google Scholar
• Galli R. The neurosphere assay (NSA) applied to neural stem cells (NSCs) and cancer stem cells (CSCs). Methods Mol Biol. 2019;1953:139–149.
   PubMedGoogle Scholar
• Huang R, Rofstad EK. Cancer stem cells (CSCs), cervical CSCs and targeted therapies. Oncotarget. 2017;8(21):35351–35367.
   PubMedGoogle Scholar
• Wang D, Jia Y, Zheng W, et al. Overexpression of eIF3D in lung adenocarcinoma is a new independent prognostic marker of poor survival. Dis Mark. 2019;2019:6019637.
   PubMed Web of Science ®Google Scholar
• Lin Z, Xiong L, Lin Q. Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer. Med Oncol. 2015;32(7):183.
   PubMed Web of Science ®Google Scholar
• Reddy RK, Mao C, Baumeister P, et al. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem. 2003;278(23):20915–20924.
   PubMed Web of Science ®Google Scholar
• Yerushalmi R, Raiter A, Nalbandyan K, et al. Cell surface GRP78: a potential marker of good prognosis and response to chemotherapy in breast cancer. Oncol Lett. 2015;10(4):2149–2155.
   PubMed Web of Science ®Google Scholar
• Qiu J, Zhou S, Cheng W, et al. LINC00294 induced by GRP78 promotes cervical cancer development by promoting cell cycle transition. Oncol Lett. 2020;20(5):262.
   PubMed Web of Science ®Google Scholar
• Liu H, Wu B, Ge Y, et al. Phosphamide-containing diphenylpyrimidine analogues (PA-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with enhanced activity against pancreatic cancer cell lines. Bioorg Med Chem. 2017;25(24):6313–6321.
   PubMed Web of Science ®Google Scholar
• Kang Y, Yoon SW, Park B. Allergenremoved Rhus verniciflua Stokes suppresses invasion and migration of pancreatic cancer cells through downregulation of the JAK/STAT and Src/FAK signaling pathways. Oncol Rep. 2018;40(5):3060–3068.
   PubMed Web of Science ®Google Scholar